Literature DB >> 16648968

P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis.

Ming Chen1, Jian-Guo Geng.   

Abstract

Stimulated endothelial cells and activated platelets express P-selectin (CD62P), a member of the selectin family of cell adhesion molecules, which interacts with P-selectin glycoprotein ligand-1 (PSGL-1, CD162) for leukocyte rolling on stimulated endothelial cells and heterotypic aggregation of activated platelets onto leukocytes. Cross-linking of PSGL-1 by P-selectin also primes leukocytes intracellularly for cytokine and chemoattractant-induced beta2-integrin activation for firm adhesion of leukocytes. Furthermore, P-selectin mediates heterotypic aggregation of activated platelets to cancer cells and adhesion of cancer cells to stimulated endothelial cells. Here we provide a comprehensive summary of the functional roles and the biological importance of P-selectin-mediated cell adhesive interactions in the pathogeneses of inflammation, thrombosis, and the growth and metastasis of cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648968     DOI: 10.1007/s00005-006-0010-6

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  70 in total

1.  P-selectin gene polymorphism associates with pulmonary hypertension in congenital heart disease.

Authors:  Xiao-Fei Li; Chun-Hui Song; Hong-Zhuan Sheng; Dong-Dong Zhen; Min Pan; Jian-Hua Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells.

Authors:  Zhiqiang Yue; Aiyun Wang; Zhijie Zhu; Li Tao; Yao Li; Liang Zhou; Wenxing Chen; Yin Lu
Journal:  Mol Cell Biochem       Date:  2015-08-30       Impact factor: 3.396

3.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

4.  Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.

Authors:  Vanessa Valdes; Michael A Nardi; Lindsay Elbaum; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

5.  Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma.

Authors:  Deniz Arik; Cavit Can; Emine Dündar; Sare Kabukçuoğlu; Özgül Paşaoğlu
Journal:  Pathol Oncol Res       Date:  2016-10-13       Impact factor: 3.201

Review 6.  Treating venous thromboembolism in patients with cancer.

Authors:  Caroline Piatek; Casey L O'Connell; Howard A Liebman
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

7.  Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques.

Authors:  Maria Sofra; Anna Antenucci; Michele Gallucci; Chiara Mandoj; Rocco Papalia; Claudia Claroni; Ilaria Monteferrante; Giulia Torregiani; Valeria Gianaroli; Isabella Sperduti; Luigi Tomao; Ester Forastiere
Journal:  J Exp Clin Cancer Res       Date:  2014-08-17

Review 8.  Biomolecular markers of cancer-associated thromboembolism.

Authors:  Diana L Hanna; Richard H White; Ted Wun
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-21       Impact factor: 6.312

Review 9.  Epidemiology of cancer-related venous thromboembolism.

Authors:  Ted Wun; Richard H White
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

10.  Variation in the upstream region of P-Selectin (SELP) is a risk factor for SLE.

Authors:  D L Morris; R R Graham; L-P Erwig; P M Gaffney; K L Moser; T W Behrens; T J Vyse; D S Cunninghame Graham
Journal:  Genes Immun       Date:  2009-04-30       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.